One-Year Outcomes Using Ranibizumab for Neovascular Age-Related Macular Degeneration: Results of a Prospective and Retrospective Observational Multicentre Study

The Swedish Lucentis Quality Registry is a 12-month, open-label, observational, prospective, and retrospective study of ranibizumab administration for wet AMD. Visual acuity (VA) was measured with Snellen or ETDRS chart in 370 patients (66.8% women; age range 46–93 years). In total, a mean of 4.7 ±...

Descripción completa

Detalles Bibliográficos
Autores principales: Hjelmqvist, Lars, Lindberg, Charlotte, Kanulf, Pär, Dahlgren, Henrik, Johansson, Ingrid, Siewert, Annica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2011
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3228303/
https://www.ncbi.nlm.nih.gov/pubmed/22174994
http://dx.doi.org/10.1155/2011/405724

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3228303/
https://www.ncbi.nlm.nih.gov/pubmed/22174994
http://dx.doi.org/10.1155/2011/405724

Ejemplares similares